Growth Equity

As the AI coding market heats up, Cursor's strategic hire of Brian McCarthy signals a major push for enterprise dominance against rivals like GitHub Copilot.

A new alliance between Tend Health and SafeHavenMD offers a confidential lifeline to doctors battling burnout, integrating peer support with clinical care.

With a new flexible, founder-first model, Activation Capital's Frontier BioHealth program aims to bridge the commercialization gap for life sciences startups.

Sun Life and DentaQuest open nominations for their Health Access Hero Awards, offering grants to groups fighting critical health disparities.

The nation's top infectious disease lab partners with SYNERGEN Health, using AI to combat claim denials and future-proof its national expansion.

A simple nasal spray could offer immediate, broad protection against the flu. New landmark studies show how this antibody-based shield could revolutionize prevention.

As AI's power needs skyrocket, GridAI brings in veteran Tim Healy to lead its charge. Can his software-first approach solve the grid's biggest challenge?

With a key drug for a rare disease nearing the finish line, Spruce adds two industry veterans to navigate the high-stakes FDA approval process.

Legendary investor Eric Sprott injects $40M into Highlander Silver, fueling its world-class San Luis project and signaling a major move in the silver market.

Known for non-opioid pain relief, Scilex is diversifying with a major investment in a stealthy diagnostic firm, hinting at a new data-driven strategy.

With a $100M war chest, Propy is buying up title firms to replace manual work with AI, aiming to slash closing costs and reshape the housing market.

New platform ends 'slow data' for category teams, linking shelf space directly to sales performance with real-time, unified insights from a single source.

As GPS spoofing threatens military and infrastructure, VIAVI's IRINS offers a resilient navigation solution by combining inertial sensors with LEO satellites.

ENA Respiratory's INNA-051 nasal spray, a virus-agnostic shield, has begun Phase II trials, offering new hope for high-risk communities.

A Google-backed AI agent observes your behavior to manage your schedule. It's a leap toward true delegation, but can we trust an algorithm with our time?

A $9.7M joint investment will fast-track a perpetual robot, low-carbon cement, and tech to remove 'forever chemicals' from water.

A historic wave of business acquisitions is set to reshape Canada's economy as owners retire, unlocking immense profits for savvy buyers.

A new report reveals firms waste billions on AI due to poor data, creating a divide between those who succeed and those who fail. Are you on the right side?

CI Global Asset Management launches innovative funds combining crypto's growth and gold's stability, challenging traditional diversification with a 0% fee offer.

The tech firm's sales surge for its DriveMod Tuggers signals accelerating adoption as industries battle labor shortages with AI-powered logistics solutions.